Peptide Nanovaccine (ONVAX-01) Plus Anti-PD-1 Antibody and Chemotherapy in Advanced Pancreatic Cancer

NCT07637786 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

9

Enrollment

OTHER

Sponsor class

Conditions

Advanced Pancreatic Adenocarcinoma

Interventions

DRUG: ONVAX-01 plus Anti-PD-1 and Chemotherapy

Sponsor

Sichuan University